dc.contributor.author | Koç, Mehmet | |
dc.contributor.author | Kumral, Zarife Nigar Özdemir | |
dc.contributor.author | Özkan, Naziye | |
dc.contributor.author | Memi, Gülsün | |
dc.contributor.author | Kacar, Ömer | |
dc.contributor.author | Bilsel, Serpil | |
dc.contributor.author | Yeğen, Berrak C. | |
dc.date.accessioned | 2021-12-12T17:01:48Z | |
dc.date.available | 2021-12-12T17:01:48Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 0196-9781 | |
dc.identifier.issn | 1873-5169 | |
dc.identifier.uri | https://doi.org/10.1016/j.peptides.2014.07.019 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11857/3302 | |
dc.description.abstract | Obestatin was shown to have anti-inflammatory effects in several inflammatory models. To elucidate the potential renoprotective effects of obestatin, renal I/R injury was induced in male Sprague Dawley rats by placing a clamp across left renal artery for 60 min following a right nephrectomy. Clamp was released and the rats were injected with either saline or obestatin (10, 30, 100 mu g/kg). In some experiments, obestatin (10 mu g/kg) was administered with L-NAME (10 mg/kg) or L-Nil (0.36 mg/kg). Following a 24-h reperfusion, the rats were decapitated to measure serum creatinine and nitrite/nitrate levels, renal malondialdehyde (MDA), glutathione (GSH) levels and myeloperoxidase (MPO) activity and to assess cortical necrosis and apoptosis scores. Obestatin treatment reduced I/R-induced increase in creatinine levels, renal MPO activity and renal MDA levels, while renal GSH levels were significantly increased by obestatin. Histological analysis revealed that severe I/R injury and high apoptosis score in the kidney samples of saline-treated rats were significantly reduced and the cortical/medullary injury was ameliorated by obestatin. Expression of eNOS, which was increased by I/R injury, was further increased by obestatin, while serum NO levels were significantly decreased. iNOS inhibitor L-Nil reduced oxidative renal damage and improved the functional and histopathological parameters. I/R-induced elevation in eNOS expression, which was further increased by obestatin, was depressed by L-NAME and L-Nil treatments. The present data demonstrate that obestatin ameliorates renal I/R-injury by its possible anti-oxidative, anti-inflammatory and anti-apoptotic properties, which appear to involve the suppression of neutrophil accumulation and modulation of NO metabolism. (C) 2014 Elsevier Inc. All rights reserved. | en_US |
dc.description.sponsorship | Marmara University Research Fund, Istanbul, TurkeyMarmara University [SAG-D-010710-0219] | en_US |
dc.description.sponsorship | This work was supported by a travel grant from the Marmara University Research Fund, Istanbul, Turkey, SAG-D-010710-0219 (received by M.K.). | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Peptides | en_US |
dc.identifier.doi | 10.1016/j.peptides.2014.07.019 | |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Obestatin | en_US |
dc.subject | Renal ischemia-reperfusion injury | en_US |
dc.subject | Nitric oxide | en_US |
dc.subject | Oxidative stress | en_US |
dc.title | Obestatin improves ischemia/reperfusion-induced renal injury in rats via its antioxidant and anti-apoptotic effects: Role of the nitric oxide | en_US |
dc.type | article | |
dc.authorid | Yegen, Berrak/0000-0003-0791-0165 | |
dc.authorid | KUMRAL, Zarife Nigar OZDEMIR/0000-0002-9485-0174 | |
dc.authorid | Yegen, Berrak C./0000-0003-0791-0165 | |
dc.department | Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri, Biyofizik Ana Bilim Dalı | |
dc.identifier.volume | 60 | en_US |
dc.identifier.startpage | 23 | en_US |
dc.identifier.endpage | 31 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57194106768 | |
dc.authorscopusid | 57188552406 | |
dc.authorscopusid | 24173597900 | |
dc.authorscopusid | 55760361800 | |
dc.authorscopusid | 49461395600 | |
dc.authorscopusid | 36882596600 | |
dc.authorscopusid | 6701675748 | |
dc.identifier.wos | WOS:000342364900005 | en_US |
dc.identifier.scopus | 2-s2.0-84906085127 | en_US |
dc.identifier.pmid | PubMed: 25086266 | en_US |
dc.authorwosid | Yegen, Berrak/ABA-3274-2020 | |
dc.authorwosid | Yegen, Berrak/O-6652-2017 | |
dc.authorwosid | KUMRAL, Zarife Nigar OZDEMIR/AAG-1861-2020 | |
dc.authorwosid | KOC, Mehmet/U-5525-2019 | |
dc.authorwosid | Yegen, Berrak C./ABA-1986-2020 | |